Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (1): 48-53    DOI: 10.31083/j.ejgo.2020.01.4985
Original Research Previous articles | Next articles
Magnetic seed localisation for non-palpable lesions in patients undergoing breast conservative surgery
A. Conversano1, *(), C. Balleyguier2, M.K. De Fremicourt1, H. Alkhashnam1, C. Mazouni1, J. Arfi-Rouche2, N. Leymarie1, F. Rimareix1
1 Service de Chirurgie Sénologique, Plastique et Reconstructrice, Gustave Roussy Hospital, Villejuif, France
2 Service de Radiologie, Gustave Roussy Hospital, Villejuif, France
Download:  PDF(1765KB)  ( 309 ) Full text   ( 14 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: Breast-conservative surgery is the standard procedure for breast cancer when tumour resection does not lead to significant cosmetic sequelae. The usual technique to locate non-palpable lesions is the wire-guided localization (WGL). However, the WGL may migrate and cause interference with the electro cautery. The placement of the WGL has to be performed on the day before or the day of the surgery, causing organizational problems. To optimize care pathway and increase ambulatory activity, the authors studied the feasibility and efficacy of a 5-mm iron seed MAGSEED. Materials and Methods: During four months, 20 seeds were placed in 19 patients undergoing a lumpectomy for non-palpable breast lesions. The evaluation questionnaire was filled by radiologists, surgeons, and patients. Results: All clips were detected. The radiological and surgical team found the MAGSEED simple and intuitive. Placement was done by ultrasound and stereotaxic guidance up to 15 days before surgery. Time of lumpectomy was reduced to an average of 11 minutes. Patients' pain level was low (2/10). Conclusion: The use of MAGSEED for the detection of non-palpable breast lesions is simple, safe, and feasible. A comparative randomized prospective study should be performed between MAGSEED and WGL to study the medico-economic outcomes and the surgical and radiological benefits of the magnetic seed.
Key words:  Magnetic seed      Breast cancer      Localization      Wire      Lumpectomy     
Published:  15 February 2020     
*Corresponding Author(s):  A. CONVERSANO     E-mail:  angelica.conversano@gustaveroussy.fr

Cite this article: 

A. Conversano, C. Balleyguier, M.K. De Fremicourt, H. Alkhashnam, C. Mazouni, J. Arfi-Rouche, N. Leymarie, F. Rimareix. Magnetic seed localisation for non-palpable lesions in patients undergoing breast conservative surgery. European Journal of Gynaecological Oncology, 2020, 41(1): 48-53.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.01.4985     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I1/48

[1] Polyana Barbosa Silva, Millena Prata Jammal, Márcia Antoniazi Michelin, Eddie Fernando Cândido Murta. Phenotypic differences of tecidual TDCs obtained from breast cancer mice[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 689-698.
[2] Huifen Zhen, Fan Guo, Xiaojun Zhang, Miaomiao Jia, Haibo Yang, Yarong Yao, Yuandong Li, Jinnan Gao. The effects of chemotherapy with anthracyclines vs capecitabine on tumour size, survival rate and estradiol levels in patients with locally advanced breast cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 785-789.
[3] Katselashvili Lika, Jokhadze Natia, Katcharava Margarita, Vardiashvili Nino. Breast Cancer Metastatic to Vulva - a Case Report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 845-848.
[4] Hayal Uzelli Şimşek, Turgay Şimşek, Deniz Şahin, Sertaç Ata Güler, Nuh Zafer Cantürk, Nihat Zafer Utkan. Evaluation of the effect of surgical timing on systemic response to trauma in premenopausal patients by using cytokine levels[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 577-582.
[5] Isao Otsuka. Clear cell carcinoma of the vagina followed by breast cancer in a patient without prenatal diethylstilbestrol exposure[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 638-639.
[6] Luca Roncati, Maria Vadalà, Pepe Valentina, Veronica Corazzari, Beniamino Palmieri. Genomic profiling in gynaecological oncology: the future is now![J]. European Journal of Gynaecological Oncology, 2020, 41(3): 323-325.
[7] D. Korfias, J. Contis, M. Frangou-Plemenou, K. Gennatas, A. Kondis, D. Vlachodimitropoulos. Stem cells in ductal breast cancer: immunohistochemical expression of CD44, CD24, CD133, and ALDH-1 markers in 104 cases[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 36-41.
[8] S.Wang, W.J. Chen, Z.M. Song, Q. Li, X. Shen, Y.D. Wu, L. Zhu, Q.X. Ma, D.M. Xing. Long non-coding RNA ROR accelerates the progression of breast cancer via promoting stemness in MCF-10A cells[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 106-109.
[9] M. Englert-Golon, B. Burchardt, R. Słopień, N. Smolarek, S. Sajdak. Ovarian and endometrial cancer after breast cancer - three primary malignancies in a single patient[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 153-154.
[10] T. Aizawa, T. Maebayashi, N. Ishibashi, M. Sakaguchi. Bilateral organizing pneumonia after radiotherapy for bilateral synchronous breast cancers: a case report and literature review[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1051-1054.
[11] M. El Homsi, A. Barakat, R. Rammal, M. Haidar. Uterine metastasis from invasive ductal breast carcinoma mimicking fibroid features on MRI and detected by FDG PET/CT: role of SUVmax[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1079-1082.
[12] S. Dierckxsens, B. Geerinckx, M.T. Huizing, W.A.A. Tjalma. A review regarding the feasibility and accuracy of a sentinel lymph node biopsy after neo-adjuvant chemotherapy for breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 714-721.
[13] M. Pakiž, L. Lukman, N. Kozar. Patients’ and physicians’ expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781-786.
[14] S. Bertozzi, A. P. Londero, S. Bernardi, C. Cedolini. Applicability of the Notthingham Prognostic Index for predicting the survival of triple-negative invasive breast cancer in a single Italian center[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 787-790.
[15] C. Cedolini, S. Bertozzi, A. P. Londero, I. Pradelle, S. Bernardi, V. Londero, A. Uzzau, M. Bazzocchi, C. Zuiani, A. Risaliti. Risk factors for breast cancer development in patients with borderline breast lesions: a retrospective analysis of our outpatient facility[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 572-578.
No Suggested Reading articles found!